MAU2

Across TCGA pan-cancer cohorts, MAU2 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated MAU2 data layer compared with 28 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MAU2 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated MAU2 expression acts as an unfavorable survival marker, although some lineages such as CCRCC show a favorable association.

UCEC, HNSC, and OV are the cancer types where MAU2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	III,IV	0.205	0.853	<.001	38	view →
HNSC	OS	Median	III,IV	0.783	0.924	.005	36	view →
OV	DFS	Median	All	0.867	1.000	.036	4	view →
CCRCC	DFS	Median	All	0.900	0.514	.011	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MAU2–UCEC (DFS)

Open the UCEC breakdown →